Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

246
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
246
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

97
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
97

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Mucoid Pseudomonas aeruginosa-derived alginate modulates innate immune transcriptional responses and promotes intracellular growth of Mycobacterium tuberculosis and non-tuberculous mycobacteria.

Microbial pathogenesis·2026
Same author

Progranulin as a context-dependent regulator of innate immunity in bacterial infections.

Cytokine·2026
Same author

Antimicrobial proteins and peptides in pregnancy: Guardians of the maternal-fetal frontier.

Frontiers in immunology·2026
Same author

Multi-species Microbial Modulation of the RANK/RANKL (Receptor Activator of Nuclear Factor κB/Receptor Activator of Nuclear Factor κB Ligand) Pathway Induces Osteoclastogenic Priming in Apical Periodontitis.

Cureus·2026
Same author

Detection of drug resistance mutations and spoligotype mapping in Mycobacterium tuberculosis using deeplex sequencing, including novel and uncharacterized spoligotypes.

Archives of microbiology·2026
Same author

Human β-defensin-3 as a transcriptional convergence point linking innate immunity, endocrine signals, and tissue repair.

Peptides·2026

相关实验视频

Updated: Sep 17, 2025

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.0K

结核病药物的开发;诺基诺的结构定制.

Alicia M Gutiérrez-Mauricio1,2, Juan Valentín Trujillo-Paez3, Luis Alberto Trejo-Martinez4

  • 1Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Zacatecas, Mexico.

The Journal of antibiotics
|July 2, 2025
PubMed
概括

新的诺基诺 (FQ) 药物显示出对抗多药耐药结核病 (TB) 的前景. 研究重点是新型合成FQ分子,以应对Mycobacterium结核病耐药性的全球挑战.

更多相关视频

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.0K
Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

7.5K

相关实验视频

Last Updated: Sep 17, 2025

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.0K
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.0K
Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

7.5K

科学领域:

  • 微生物学 微生物学
  • 药理学 药理学是指药理学的学科.
  • 传染性疾病 传染性疾病

背景情况:

  • 由Mycobacterium tuberculosis (Mtb) 引起的结核病 (TB) 仍然是全球传染病死亡的主要原因.
  • 多抗药性Mtb菌株的出现需要开发新的治疗策略.
  • 诺基诺 (FQ) 是广泛的抗生素,对于治疗耐药结核病至关重要.

研究的目的:

  • 审查新型诺基诺 (FQ) 分子的合成和抗结核活性的最新进展.
  • 突出结构修改对抗多药耐药结核病 (MDR-TB) 的FQ疗效的影响.

主要方法:

  • 关于诺基诺合成和抗结核活性最近研究的文献综述.
  • 分析旨在增强FQ功效和克服阻力机制的结构修改.
  • 对各种菌株的FQ疗效的评估Mycobacterium结核病菌,包括多药耐药的分离物.

主要成果:

  • 几种新合成的FQ衍生物在体外对Mtb.表现出显著的活性.
  • 结构性修改导致了改善的药物动力学特性,如提高组织透率和降低毒性.
  • 新兴的FQ世代在克服Mtb现有的抵抗模式方面表现出潜力.

结论:

  • 新型诺基诺为开发抗多药耐药结核病新疗法提供了一个有前途的途径.
  • 对FQ的合成修饰的持续研究对于应对全球结核病疫情至关重要.
  • 这些进展为更有效地管理具有挑战性的结核病例提供了希望.